Genome-wide Polygenic Risk Scores Predict Risk of Glioma and Molecular Subtypes.
Taishi NakaseGeno A GuerraQuinn T OstromTian GeBeatrice S MelinMargaret WrenschJohn K WienckeRobert B JenkinsJeanette E Eckel-Passownull nullMelissa L BondyStephen S FrancisLinda KachuriPublished in: Neuro-oncology (2024)
Genome-wide PRS has potential to enhance the detection of high-risk individuals and help distinguish between prognostic glioma subtypes.